子宫肌瘤随机对照试验主要与次要结局选择:系统综述
该系统综述检索MEDLINE、PubMed、EMBASE和CINAHL(建库至2021年7月)的英文随机对照试验,评估子宫肌瘤治疗结局的选择。共纳入60项RCT(5699例参与者),报告23个主要结局和173个次要结局,结局指标存在显著异质性,且无主要结局映射至生育领域,提示需建立核心结局集。
要点
- 60项RCT报告23个主要结局和173个次要结局,异质性显著
- 最常见主要结局为术后疼痛、生活质量和月经出血
- 无主要结局映射至生育领域,需建立核心结局集
核心结论
- 子宫肌瘤随机对照试验报告的结局存在显著异质性,需要建立核心结局集以更好理解不同治疗的效果。
研究设计与样本
- 系统综述,检索MEDLINE、PubMed、EMBASE和CINAHL(建库至2021年7月)的英文随机对照试验,由两名评价者独立按PRISMA方法筛选,共纳入60项RCT(5699例参与者)。
主要发现
- 60项RCT共报告23个主要结局(23种结局指标)和173个次要结局(95种结局指标)。
- 报告频率最高的主要结局领域为出血和生活质量,最常见的主要结局为术后疼痛、生活质量和月经出血。
- 无主要结局映射至生育领域。
- MOMENT结局评分中位数为5(四分位距3),且与JADAD评分(r=0.491,P=0.0001)、发表期刊影响因子(r=0.419,P=0.008)和发表年份(r=0.332,P=0.01)相关。
临床怎么用
- 临床解读子宫肌瘤RCT证据时需注意结局指标不统一,难以直接比较不同治疗的效果。
- 未来研究应参考核心结局集的发展方向,关注生育相关结局的纳入。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Core outcome sets aim to reduce research heterogeneity and standardise reporting, allowing meaningful comparisons between studies. OBJECTIVES: To report on outcomes used in randomised controlled trials (RCTs) investigating uterine fibroid treatments, towards the development of a core outcome set for fibroid research. SELECTION STRATEGY: Database search of MEDLINE, PubMed, EMBASE and CINAHL (inception to July 2021) for all English-language RCTs involving surgical or radiological fibroid treatments. DATA COLLECTION AND ANALYSIS: A total of 1885 texts were screened for eligibility by two reviewers independently according to PRISMA methodology. JADAD and Management of Otitis Media with Effusion in Cleft Palate (MOMENT) scores were used to assess methodological and outcome reporting quality of studies, respectively. Outcomes were mapped to nine domains. Non-parametric tests for correlation and to compare group medians were undertaken. MAIN RESULTS: There were 23 primary outcomes (23 outcome measures) and 173 secondary outcomes (95 outcome measures) reported in 60 RCTs (5699 participants). The domains with highest frequency of primary outcomes reported were bleeding and quality of life (QoL). The most frequent primary outcomes were postoperative pain, QoL and menstrual bleeding. No primary outcomes were mapped to fertility domains. Median MOMENT outcome score was 5 (interquartile range 3). There was correlation between MOMENT outcome score and JADAD scores (r = 0.491, P = 0.0001), publishing journal impact factor (r = 0.419, P = 0.008) and publication year (r = 0.332, P = 0.01). CONCLUSION: There is substantial variation in the outcomes reported in fibroid RCTs. There is a need for a core outcome set for fibroid research, to allow improved understanding regarding the effects of different treatments. TWEETABLE ABSTRACT: There is substantial variation in outcomes reported in uterine fibroid randomised controlled trials.
引用
- Amoah A, Chiu S, Quinn SD, et al. Choice of primary and secondary outcomes in randomised controlled trials evaluating treatment for uterine fibroids: a systematic review. BJOG. 2021. PMID: 34536313. doi:10.1111/1471-0528.16933
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。